Compare UBCP & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBCP | SEER |
|---|---|---|
| Founded | 1902 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.6M | 108.0M |
| IPO Year | 1995 | 2020 |
| Metric | UBCP | SEER |
|---|---|---|
| Price | $16.00 | $1.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.9K | ★ 152.6K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | 5.51 | ★ 9.40 |
| EPS | ★ 0.69 | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | $5.58 | $25.90 |
| P/E Ratio | $22.80 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $12.55 | $1.55 |
| 52 Week High | $17.34 | $2.41 |
| Indicator | UBCP | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 53.61 | 36.77 |
| Support Level | $14.91 | $1.83 |
| Resistance Level | $16.03 | $1.94 |
| Average True Range (ATR) | 0.27 | 0.04 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 77.69 | 33.33 |
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which include accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. The Company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are residential mortgage, commercial, and installment loans. The bank also operates in Marshall County, West Virginia.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.